Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline BOSTON, July 27, 2015 (GLOBE NEWSWIRE) -- Gelesis, a clinical stage biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control,...

Gelesis Presents Additional Data at European Congress on Obesity BOSTON, May 22, 2015 (GLOBE NEWSWIRE) -- Gelesis, a clinical stage biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control,...